Home › Funds › Pzena Investment Management › FMS
Pzena Investment Management position in FMS
FRESENIUS MEDICAL CARE AG · Health Care
Pzena Investment Management reported holding 16,617,575 shares of FMS (FRESENIUS MEDICAL CARE AG) in its Q3 2026 13F filing — a position valued at US$371.9M, representing 1.09% of its reported portfolio and ranking #28 among its reported holdings. Pzena Investment Management has disclosed FMS holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Pzena Investment Management's FMS position evolved
Pzena Investment Management first disclosed a stake in FMS in Q3 2021 at 6,407,774 shares (US$224.1M). The position peaked in Q1 2023 at 20,025,078 shares, worth US$425.7M. Across 21 filings, Pzena Investment Management increased the stake 8 time(s), trimmed it 6 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 16,617,575 shares valued at US$371.9M — an increase of 1,625,494 shares quarter over quarter.. Notable position changes include a 48% increase in Q4 2021 (shares rose 4% over the following quarter), a 85% increase in Q4 2022 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.41M | $224.08M | New |
| Q4 2021 | 9.46M | $307.05M | Add |
| Q1 2022 | 11.58M | $389.94M | Add |
| Q2 2022 | 13.18M | $328.61M | Add |
| Q3 2022 | 13.12M | $184.25M | Hold |
| Q4 2022 | 24.33M | $397.59M | Add |
| Q1 2023 | 20.03M | $425.73M | Reduce |
| Q2 2023 | 16.67M | $398.97M | Reduce |
| Q3 2023 | 16.29M | $350.86M | Reduce |
| Q4 2023 | 16.27M | $338.85M | Hold |
| Q1 2024 | 16.27M | $313.72M | Hold |
| Q2 2024 | 16.18M | $308.96M | Reduce |
| Q3 2024 | 16.22M | $345.39M | Hold |
| Q4 2024 | 15.28M | $346.01M | Reduce |
| Q1 2025 | 15.38M | $382.89M | Add |
| Q2 2025 | 14.66M | $418.92M | Reduce |
| Q3 2025 | 14.82M | $390.13M | Add |
| Q4 2025 | 14.75M | $351.41M | Hold |
| Q1 2026 | 15.05M | $339.59M | Add |
| Q2 2026 | 14.99M | $338.97M | Hold |
| Q3 2026 | 16.62M | $371.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FMS and 13F data
FMS (FRESENIUS MEDICAL CARE AG) is a Health Care company. 31 other funds we track also report a position in FMS — the largest reported positions include ABC ARBITRAGE SA (US$14.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Pzena Investment Management
FAQ
How long has Pzena Investment Management held FMS?
Pzena Investment Management has disclosed FMS holdings in 21 of the last 21 reported quarters, going back to Q3 2021.
What is Pzena Investment Management's current position in FMS?
As of Q3 2026, Pzena Investment Management holds 16.62M shares of FMS (FRESENIUS MEDICAL CARE AG), valued at $371.90M, representing 1.09% of its reported portfolio and ranking #28.
Has Pzena Investment Management been buying or selling FMS?
In the latest 13F filing (Q3 2026), Pzena Investment Management increased its position in FMS. The position peaked in Q1 2023 at 20.03M shares.
Which other funds hold FMS?
Other major institutional holders of FMS include ABC ARBITRAGE SA, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.